Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

HHS Secretary Robert F. Kennedy Jr. places anti-vaxxers in control of U.S. vaccine policy, slandering an actual expert along ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...

AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...

Fat steers and heifers filled the pens at the Finney County Fairgrounds in the early morning hours of June 3, waiting to be ...

The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.

ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILING Poster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...